Over-expression of MRP, BCRP and P-gp, as a classical drug resistance mechanism, can increase the efflux capacity of cells to chemotherapeutic drugs, making drug accumulation decrease or even disappear and then reducing the toxicity to cancer cells [31]. Here, ABCC1 is linked to cancer.